Hear from Model N and BRG as they explore how the new MFP regulation under the IRA intersects with the 340B Rebate Model, and what it means for manufacturers, covered entities, and stakeholders across the healthcare ecosystem.

This session will provide an overview of the MFP regulation introduced under the IRA, its intersection with the 340B Rebate Model, and the operational challenges it poses. We will discuss how Model N, in collaboration with BRG, is designed to streamline IRA-related compliance, automate calculations, and support stakeholders in adapting to these evolving requirements.

What You’ll Learn:

• Key IRA and MFP requirements, and how they impact drug pricing and compliance.
• The essentials of the 340B Rebate Model and rebate processes.
• How Model N and BRG automate compliance and streamline operations.
• Practical steps for manufacturers and stakeholders to prepare for upcoming changes.

Watch industry experts as they dissect these key areas, offering practical guidance to enhance your organization’s governance, improve internal processes, and ensure alignment with the latest industry standards.

Peter Glass

Senior Managing Consultant

BRG

Neeraj Jha

Sr. Director, Professional Services

Model N

Tony George

Director, Product Management

Model N